370 related articles for article (PubMed ID: 32429374)
21. Use of a probiotic to decrease enteric hyperoxaluria.
Lieske JC; Goldfarb DS; De Simone C; Regnier C
Kidney Int; 2005 Sep; 68(3):1244-9. PubMed ID: 16105057
[TBL] [Abstract][Full Text] [Related]
22. Oxalate metabolism after intestinal bypass operations.
Nordenvall B; Backman L; Larsson L
Scand J Gastroenterol; 1981 Apr; 16(3):395-9. PubMed ID: 16435482
[TBL] [Abstract][Full Text] [Related]
23. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
[TBL] [Abstract][Full Text] [Related]
24. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
25. [Nutritional intervention in the control of gallstones and renal lithiasis].
Martínez García RM; Jiménez Ortega AI; Salas-González MªD; Bermejo López LM; Rodríguez-Rodríguez E
Nutr Hosp; 2019 Aug; 36(Spec No3):70-74. PubMed ID: 31368343
[TBL] [Abstract][Full Text] [Related]
26. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
[TBL] [Abstract][Full Text] [Related]
27. [Diet in the treatment of renal lithiasis. Pathophysiological basis].
Negri AL; Spivacow FR; Del Valle EE
Medicina (B Aires); 2013; 73(3):267-71. PubMed ID: 23732207
[TBL] [Abstract][Full Text] [Related]
28. Nutritional and metabolic complications of bariatric surgery.
Malinowski SS
Am J Med Sci; 2006 Apr; 331(4):219-25. PubMed ID: 16617238
[TBL] [Abstract][Full Text] [Related]
29. Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies.
Canales BK; Hatch M
Surg Obes Relat Dis; 2014; 10(4):734-42. PubMed ID: 24969092
[TBL] [Abstract][Full Text] [Related]
30. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
[TBL] [Abstract][Full Text] [Related]
31. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery.
Sakhaee K; Griffith C; Pak CY
Surg Obes Relat Dis; 2012; 8(1):67-72. PubMed ID: 21703942
[TBL] [Abstract][Full Text] [Related]
32. [Oxalate: a poorly soluble organic waste with consequences].
Lu Y; Bonny O
Praxis (Bern 1994); 2015 Mar; 104(7):353-9. PubMed ID: 25804778
[TBL] [Abstract][Full Text] [Related]
33. Bariatric surgery, hyperoxaluria, and nephrolithiasis: a plea for close postoperative management of risk factors.
Kleinman JG
Kidney Int; 2007 Jul; 72(1):8-10. PubMed ID: 17597787
[TBL] [Abstract][Full Text] [Related]
34. [Oxalate: from physiology to pathology].
Grocholski C; Derain Dubourg L; Guebre-Egziabher F; Acquaviva-Bourdain C; Abid N; Bacchetta J; Chambrier C; Lemoine S
Nephrol Ther; 2023 Jun; 19(3):201-214. PubMed ID: 37166780
[TBL] [Abstract][Full Text] [Related]
35. [Bariatric surgery, calcium oxalate urinary stones and oxalate nephropathy].
Montagnac R; Schendel A; Vuiblet V; Peilleron B; Piot O
Nephrol Ther; 2011 Feb; 7(1):38-45. PubMed ID: 21130057
[TBL] [Abstract][Full Text] [Related]
36. General and dietary oxalate restriction advice reduces urinary oxalate in the stone clinic setting.
Kaestner L; Meki S; Moore A; van Woerden C; Lazarus J
S Afr J Surg; 2020 Dec; 58(4):210-212. PubMed ID: 34096208
[TBL] [Abstract][Full Text] [Related]
37. Nutrition and Kidney Stone Disease.
Siener R
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34204863
[TBL] [Abstract][Full Text] [Related]
38. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
[TBL] [Abstract][Full Text] [Related]
39. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass.
Agrawal V; Liu XJ; Campfield T; Romanelli J; Enrique Silva J; Braden GL
Surg Obes Relat Dis; 2014; 10(1):88-94. PubMed ID: 23953730
[TBL] [Abstract][Full Text] [Related]
40. Pharmacotherapy of kidney stones.
Pak CY
Expert Opin Pharmacother; 2008 Jun; 9(9):1509-18. PubMed ID: 18518781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
